Restricted Area
register »

Program

CIMT 2005 meets German Research Council Project Grant 432
"Mechanisms of tumor defense and their therapeutic manipulations"


Cancer Immunotherapy 2005 - Thursday, May 12

  • 08:20-08:30:
    Welcoming Address
    Christoph Huber, Mainz
Session 1:
"Principles of Antibody Therapy"
Chairperson: Martin Gramatzki, Kiel
  • 08:30-09:00:
    "Human Antibodies as next generation therapeutics"
    Jan van de Winkel, Utrecht, Netherland

  • 09:00-09:30:
    "Role of radioimmunoconjugates for tumor therapy"
    John Pagel, Seattle, USA

  • 09:30-10.00:
    „Targeting and killing by toxin immunoconjugates"
    Ira Pastan, Bethesda, USA

  • 10:00-10:30:
    Coffee Break
Session 2:
"Antibodies in Clinical Use - New Developments"
Chairperson: Christoph Huber, Mainz
  • 10:30-10:50:
    "Targeting the EGFR pathways: Strategies"
    Winfried Wels, Frankfurt/Main, Germany

  • 10:50-11:10:
    "Targeting the EGFR pathways in the clinic"
    Norbert Schleucher, Hamburg, Germany

  • 11:10-11:40:
    "Bevacizumab-targeting soluble mediators of angiogenesis"
    Christos Emmanouilides, Los Angelas, USA

  • 11:40-12:00:
    "Chemoimmunoconjugates for AML therapy"
    Matthias Theobald, Mainz, Germany

  • 12:00-12:20:
    "Campath-1H-beyond B-CLL therapy"
    Roland Repp, Kiel, Germany

  • 12:20-13:40:
    Lunch

  • 13:40-14:50:
    Poster Session 1: "Modulation of Immune Responses"
    Chairperson: Thomas Wölfel, Mainz
    [at the same time as]

  • Poster Session 2: "Vaccination A"
    Chairperson: Michael Schmitt, Ulm
Session 3:
"Perspectives of Antibody-based Immunotherapy"
Chairperson: Jan van de Winkel, Utrecht
  • 14:50-15:20:
    "Antibodies targeting IL-6 mediated pathways in multiple myeloma and regulatory T-cells"
    John Wijdenes, Besançon, France

  • 15:20-15:50:
    "Using antibodies to redirect lymphocytes to tumor cells"
    Zelig Eshhar, Rehovot, Israel

  • 15:50-16:20:
    "Immunocytokines"
    Stephen Gillies, Billerica, USA

  • 16:20-16:50:
    Coffee Break

  • 16:50-17:10:
    "CD19 as a target antigen for antibody-based immunotherapy"
    Julia Stieglmaier, Erlangen, Germany

  • 16:10-17:30:
    "Novel targets for cancer antibody therapy"
    Ugur Sahin, Mainz, Germany
    CIMT Workgroup Report

  • 17.30 – 17.40:
    Workgroup B: "Monitoring of T cell Responses"
    Cedrik Britten, Mainz, Germany

Special Lecture
  • 17:40-18:20:
    "Antigen Recognition by T Cell Receptor Gene Modified Cells"
    Michael Nishimura, Chicago, USA

  • 19:30:
    Dinner at Mollers’ Restaurant
Zum Seitenanfang
Cancer Immunotherapy 2005 - Friday, May 13

Session 1:
"Antigen Processing and Presentation"
Chairpersons: Hansjörg Schild and Matthias Theobald, Mainz

  • 08:30-09:10:
    "Accessing the Endogenous Class I Processing Pathway: The Plot Thickens"
    Jon Yewdell, Bethesda, USA

  • 09.10-09:50:
    "Cross-presentation and dendritic cell licensing in viral immunity"
    Bill Heath, Melbourne, Australia

  • 09:50-10:30:
    "Cross-priming soluble proteins by dendritic cells: transit times and routes"
    Herman Eisen, Cambridge, USA

  • 10:30-11:00:
    Coffee Break

Session 2:
"Activation and Suppression of Immune responses"
Chairpersons: Helmut Jonuleit and Susanne Strand, Mainz

  • 11:00-11:40:
    "Regulatory dendritic cells expressing indoleamine 2,3 dioxigenase (IDO)"
    Andrew Mellor, Augusta, USA

  • 11:40-12:20:
    "Activation and Deactivation of Suppressor T cell function"
    Ethan Shevach, Bethesda, USA

  • 12:20-13:00:
    "Activating and Maintaining CD8+ T cells"
    Michael Bevan, Seattle, USA

  • 13:00-14:00:
    Lunch

  • 14:00-15:00:
    Poster Session 3: "Vaccination B"
    Chairperson: Eckhart Kämpgen, Erlangen
    [at the same time as]

  • Poster Session 4: "Cellular Therapy"
    Chairperson: Michael Nishimura, Chicago

Session 3:
"Innate and Adaptive Immunity"
Chairpersons: Thomas Wölfel and Ugur Sahin, Mainz

  • 15:00-15:40:
    "The recognition of nucleic acid via Toll-like receptors"
    Stefan Bauer, Munich, Germany

  • 15:40-15:55:
    "Anti-tumor immunotherapy by direct injection of stabilized messenger RNA"
    Steve Pascolo, Tübingen, Germany

  • 15:55-16:15:
    Coffee Break

Session 3: continued

  • 16:15-16:55:
    "The ‘Blood-Tumor’ Barrier: Integrating Tumor Growth, Neovascularization and Immune Evasion"
    Ruth Ganss, Heidelberg, Germany

  • 16:55-17:35:
    "Visualizing Cellular Traffic in Lymph Nodes"
    Cornelia Halin, Zurich, Switzerland

  • 17.35-17:45:
    Final Remarks
    Hansjörg Schild, Mainz

Zum Seitenanfang
Download

Program as PDF-file (1,2 MB)

 
[ Back ]

ToTop